For the Press

Boston to Set the Stage for Leading Research and Advancement in the Surgical Treatment of Cancer

Author: SSO Staff
Jan 25, 2016

World-Renowned Leaders in Surgical Oncology to Share Insight on the Future of Cancer Treatment at 69th SSO Annual Cancer Symposium

ROSEMONT, IL – The Society of Surgical Oncology (SSO) will host the 69th SSO Annual Cancer Symposium March 2-5, 2016 at the John B. Hynes Veterans Memorial Convention Center in Boston. The conference will draw more than 1,700 of the brightest minds in surgical oncology from around the world for four days of education, groundbreaking research and networking.  

“Boston boasts a medical community complete with some of the most prestigious hospitals and medical schools in the world, setting the perfect stage for a week of revolutionary discovery in surgical oncology,” said Jeffrey A. Drebin, MD, PhD, president of SSO. “Health care professionals and academic practitioners from all surgical oncology specialties have long relied on the SSO Annual Cancer Symposium to gain advanced knowledge and experience hands-on interaction with the latest developments in surgical oncology.”  

SSO 2016 will feature four lectures from some of the most inspirational and accomplished oncology professionals:

  • Leading cancer researcher and surgeon, Steven A. Rosenberg, MD, PhD, Chief of Surgery at the National Cancer Institute. Dr. Rosenberg pioneered the development of effective immunotherapies and gene therapies for patients with advanced cancers. At SSO 2016, he will present the James Ewing Lecture, “T Cells as a Drug for the Treatment of Human Cancer.” 
  • José Baselga, MD, PhD, Physician-in-Chief and Chief Medical Officer at Memorial Sloan Kettering Cancer Center. Dr. Baselga will deliver “Bringing Precision Cancer Medicine Forward” as the John Wayne Clinical Research Lecture. He and the rest of his team at Memorial Sloan Kettering Cancer Center are part of Vice President Biden’s national mission to find a cure for cancer – which was addressed during President Obama’s final State of the Union address.
  • SSO President Jeffrey A. Drebin, MD, PhD, The John Rhea Barton Professor and Chair, Department of Surgery at the University of Pennsylvania. Dr. Drebin will give the SSO Presidential Address, "Translational Cancer Research: The Surgeon's Role."
  • David A. Tuveson, MD, PhD, Professor and Director of the Lustgarten Foundation Pancreatic Research Laboratory at CSHL, Cold Spring Harbor Laboratory. Dr. Tuveson will present “Pancreatic Models and Medicine" as the American Cancer Society/SSO Basic Science Lecture.  

One of the most popular elements of the SSO Annual Cancer Symposium is The Great Debates where some of the world’s leading surgical oncologists debate controversial topics in topical procedures and treatments. This year the selected panels will argue both sides of these timely topics:

  • Resectable Pancreatic Head Adenocarcinoma: Resect First
  • Public Reporting of Hospital and Provider Level Outcomes
  • Resection of Primary Colorectal Cancer with Unresectable Metastatic Disease
  • Surgeons Should Discourage Women from Undergoing Contralateral Prophylactic Mastectomy  
SSO 2016 will focus on the cancer treatments of tomorrow that can be applied to today’s surgical patients with solid tumor cancers including breast, colorectal, endocrine, gastrointestinal, head and neck, liver and pancreas, melanoma, and sarcoma. In addition to featured lectures and The Great Debates, SSO 2016 will include plenary sessions, parallel sessions, workshops, more than 400 compelling poster sessions, late-breaking videos and an array of networking opportunities. There will also be an exhibition featuring some of the latest and most advanced medical equipment, services and solutions for surgical oncologists.  

“SSO 2016 is an opportunity to explore some of the most important medical findings of the year in cancer treatment,” Dr. Drebin added. “It’s a place where leading minds in surgical oncology come together to explore the future of treatment, diagnosis and management of cancer.”  

About the Society of Surgical Oncology

The Society of Surgical Oncology (SSO) is the premier organization for surgeons and health care providers dedicated to advancing and promoting the science and treatment of cancer. The Society’s focus on all solid-tumor disease sites is reflected in its Annual Cancer Symposium, monthly scientific journal (Annals of Surgical Oncology), educational initiatives, and committee structure. The Society’s mission is to improve multidisciplinary patient care by advancing the science, education, and practice of cancer surgery worldwide.